New insights into the expression and role of platelet factor XIII-A

Journal of Thrombosis and Haemostasis

Volumn 7, Issue 7, 2009, Pages 1184-1191

  Jayo, A ^a   Conde, I ^a   Lastres, P ^a   Jimenez yuste V ^b   Gonzalez manchon C ^a,c  

^a CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

FXIII A; Platelet activation; Transglutaminase activity

Indexed keywords

BLOOD CLOTTING FACTOR 8A; DANSYLCADAVERINE; FIBRINOGEN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; THROMBIN RECEPTOR ACTIVATING PEPTIDE;

ARTICLE; BLOOD CLOTTING FACTOR 8A DEFICIENCY; BLOOD CLOTTING FACTOR DEFICIENCY; CASE REPORT; CHILD; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME REGULATION; FEMALE; FILOPODIUM; HUMAN; LAMELLIPODIUM; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE FUNCTION;

EID: 67649460715     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2009.03456.x     Document Type: Article

References (30)

1. Lorand L. Factor XIII and the clotting of fibrinogen: From basic research to medicine. J Thromb Haemost 2005; 3: 1337-48.
2. Greenberg CS, Shuman MA. The zymogen forms of blood coagulation factor.XIII bind specifically to fibrinogen. J Biol Chem 1982; 257: 6096-101.
3. Siebenlist KR, Meh DA, Mosesson MW. Plasma factor.XIII binds specifically to fibrinogen molecules containing gamma chains. Biochemistry 1996; 35: 10448-53.
4. Polgar J, Hidasi V, Muszbek L. Non-proteolytic activation of cellular protransglutaminase (placenta macrophage factor XIII). Biochem J 1990; 267: 557-60.
5. Muszbek L, Polgar J, Boda Z. Platelet factor XIII becomes active without the release of activation peptide during platelet activation. Thromb Haemost 1993; 69: 282-5.
6. Muszbek L, Yee VC, Hevessy Z. Blood coagulation factor XIII: Structure and function. Thromb Res 1999; 94: 271-305.
7. Lorand L, Graham RM. Transglutaminases: Crosslinking enzymes with pleiotropic functions. Nat Rev Mol Cell Biol 2003; 4: 140-56.
8. Adany R, Bardos H. Factor.XIII subunit. A as an intracellular transglutaminase. Cell Mol Life Sci 2003; 60: 1049-60.
9. Puszkin EG, Raghuraman V. Catalytic properties of a calmodulin-regulated transglutaminase from human platelet and chicken gizzard. J Biol Chem 1985; 260: 16012-20.
10. Muszbek L, Haramura G, Polgar J. Transformation of cellular factor XIII into an active zymogen transglutaminase in thrombin-stimulated platelets. Thromb Haemost 1995; 73: 702-5.
11. Ichinose A. Physiopathology and regulation of factor XIII. Thromb Haemost 2001; 86: 57-65.
12. Ozsoylu S, Hicsonmez G. Platelet aggregation in congenital factor XIII deficiency. Acta Haematol 1976; 56: 314-17.
13. Mikkola H, Muszbek L, Laiho E, Syrjala M, Hamalainen E, Haramura G, Salmi T, Peltonen L, Palotie A. Molecular mechanism of a mild phenotype in coagulation factor.XIII (FXIII) deficiency: A splicing mutation permitting partial correct splicing of FXIII A-subunit mRNA. Blood 1997; 89: 1279-87.
14. Egbring R, Seitz R, Gürten M. Bleeding complications in heterozygotes with congenital factor XIII deficiency. In: Mosesson M, Amrani D, Siebenlist K, Diorio J, eds. Fibrinogen: Biochemistry, Biological Functions, Gene Regulation and Expression. Amsterdam: Elsevier Science, 1988: 341-6.
15. Pabón D, Jayo A, Xie J, Lastres P, González-Manchón C. Thrombin induces GPIb-IX-mediated fibrin binding to aIIbb3 in a reconstituted Chinese hamster ovary cell model. J Thromb Haemost 2006; 4: 2238-47.
16. Bellavite P, Andrioli G, Guzzo P, Arigliano P, Chirumbolo S, Manzato F, Santonastaso C. A colorimetric method for the measurement of platelet adhesion in microtiter plates. Anal Biochem 1994; 216: 444-50.
17. Vreken P, Niessen RW, Peters M, Schaap MC, Zuithoff-Rijntjes JG, Sturk A. A point mutation in an invariant splice acceptor site results in a decreased mRNA level in a patient with severe coagulation factor.XIII subunit. A deficiency. Thromb Haemost 1995; 74: 584-9.
18. Jobe SM, Leo L, Eastvold JS, Dickneite G, Ratliff TL, Lentz SR, Di Paola J. Role of FcRgamma and factor.XIIIA in coated platelet formation. Blood 2005; 106: 4146-51.
19. Parameswaran KN, Velasco PT, Wilson J, Lorand L. Labeling of epsilon-lysine crosslinking sites in proteins with peptide substrates of factor XIIIa and transglutaminase. Proc Natl Acad Sci USA 1990; 87: 8472-5.
20. Muszbek L, Adany R, Kavai M, Boda Z, Lopaciuk S. Monocytes of patients congenitally deficient in plasma factor XIII lack factor XIII subunit. A antigen and transglutaminase activity. Thromb Haemost 1988; 59: 231-5.
21. Takahashi N, Tsukamoto H, Umeyama H, Castaman G, Rodeghiero F, Ichinose A. Molecular mechanisms of type II factor XIII deficiency: Novel Gly562-Arg mutation and C-terminal truncation of the A.subunit cause factor.XIII deficiency as characterized in a mammalian expression system. Blood 1998; 91: 2830-8.
22. Krawczak M, Thomas NS, Hundrieser B, Mort M, Wittig M, Hampe J, Cooper DN. Single base-pair substitutions in exon-intron junctions of human genes: Nature, distribution, and consequences for mRNA splicing. Hum Mutat 2007; 28: 150-8.
23. Takahara K, Schwarze U, Imamura Y, Hoffman GG, Toriello H, Smith LT, Byers PH, Greenspan DS. Order of intron removal influences multiple splice outcomes, including a two-exon skip, in a COL5A1 acceptor-site mutation that results in abnormal pro-alpha1(V) N-propeptides and Ehlers-Danlos syndrome type I. Am J Hum Genet 2002; 71: 451-65.
24. Attanasio C, David A, Neerman-Arbez M. Outcome of donor splice site mutations accounting for congenital afibrinogenemia reflects order of intron removal in the fibrinogen alpha gene (FGA). Blood 2003; 101: 1851-6.
25. Kahn ML, Zheng YW, Huang W, Bigornia V, Zeng D, Moff S, Farese RV Jr, Tam C, Coughlin SR. A dual thrombin receptor system for platelet activation. Nature 1998; 394: 690-4.
26. Serrano K, Devine DV. Intracellular factor XIII crosslinks platelet cytoskeletal elements upon platelet activation. Thromb Haemost 2002; 88: 315-20.
27. Terrillon S, Bouvier M. Roles of G-protein-coupled receptor dimerization. EMBO Rep 2004; 5: 30-4.
28. AbdAlla S, Lother H, Langer A, el Faramawy Y, Quitterer U. Factor XIIIA transglutaminase crosslinks AT1 receptor dimers of monocytes at the onset of atherosclerosis. Cell 2004; 119: 343-54.
29. Kulkarni S, Jackson SP. Platelet factor XIII and calpain negatively regulate integrin alphaIIbbeta3 adhesive function and thrombus growth. J Biol Chem 2004; 279: 30697-706.
30. Sarvary A, Szucs S, Balogh I, Becsky A, Bardos H, Kavai M, Seligsohn U, Egbring R, Lopaciuk S, Muszbek L, Adany R. Possible role of factor XIII subunit. A in Fcgamma and complement receptor-mediated phagocytosis. Cell Immunol 2004; 228: 81-90.